Skip to search.
 FTSE 100 Up 1.35%

Gilead Sciences Inc. (GILD)

-NasdaqGS
86.22 Up 2.89(3.47%) 21:00
|After Hours: : 86.40 Up 0.18 (0.21%) 22:33 - Nasdaq Real Time Price
Prev Close:83.33
Open:83.78
Bid:86.26 x 100
Ask:86.35 x 200
1y Target Est:111.29
Beta:1.25902
Earnings Date:26 Jul - 1 Aug (Est.)
Day's Range:83.71 - 86.44
52wk Range:81.28 - 123.37
Volume:13,146,203
Avg Vol (3m):10,766,100
Market Cap:114.83b
P/E (ttm):7.36
EPS (ttm):11.71
Div & Yield:1.88 (2.26%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDUp 3.47%114.83b
GSKUp 1.67%103.74b
PFEUp 1.28%206.81b

Key Statistics

Forward P/E (1 yr):6.96
P/S (ttm):3.38
Ex-Dividend Date:14-Jun-16

Analysts

Annual EPS Est (Dec-16) :12.06
Quarterly EPS Est (Jun-16) :2.99
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):5.53

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback